Ramipril Supply Limit Extended to October
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor, taken by around 6 million people. It is the most commonly prescribed antihypertensive in the UK, and among the top 10 most-prescribed medications overall. It is often preferred over other drugs because its long half-life means it can be taken just once daily.The SSP was extended in May and again on 23 July.
- ▪Ramipril is an angiotensin-converting enzyme (ACE) inhibitor, taken by around 6 million people.
- ▪It is the most commonly prescribed antihypertensive in the UK, and among the top 10 most-prescribed medications overall.
- ▪It is often preferred over other drugs because its long half-life means it can be taken just once daily.The SSP was extended in May and again on 23 July.
Medscape files mainly under health. We currently carry 231 of its stories.
Opening excerpt (first ~120 words) tap to expand
The one-month limit on ramipril 1.25 mg capsule supplies has been extended until 30 October, prompting pharmacists to renew calls to be allowed to use their professional judgement to substitute an alternative product.In April, the Department of Health and Social Care (DHSC) issued a serious shortage protocol (SSP) for ramipril 1.25 mg capsules, telling pharmacies to limit supplies to one month per prescription.Around 14 million adults in the UK have high blood pressure. Ramipril is an angiotensin-converting enzyme (ACE) inhibitor, taken by around 6 million people. It is the most commonly prescribed antihypertensive in the UK, and among the top 10 most-prescribed medications overall.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape Medical News Headlines.
Discussion
0 commentsMore from Medscape Medical News Headlines
